IPAR.NASDAQInterparfums INC
Form 4: Interparfums Director Gilbert Harrison Sells Shares Under Pre-Arranged Plan
Sentiment:
Insider Trading Report
Interparfums Inc. Director Gilbert Harrison reported the sale of 400 shares of common stock for approximately $53,584 under a Rule 10b5-1 trading plan.
Summary
- Gilbert Harrison, a Director and 10% Owner of Interparfums Inc. (IPAR), sold 400 shares of common stock.
- The transaction occurred on June 23, 2025, at a price of $133.96 per share.
- The total value of the shares sold was approximately $53,584.
- Following this sale, Mr. Harrison directly beneficially owns 1,550 shares of Interparfums common stock.
- The sale was conducted pursuant to a Rule 10b5-1 trading plan, indicating it was pre-scheduled.
- Mr. Harrison also holds various stock options to purchase a total of 6,000 shares of common stock, with exercise prices ranging from $62.18 to $147.71 and expiration dates up to December 30, 2030.
Sentiment
Score: 4
Explanation: An insider sale, even if pre-planned under Rule 10b5-1, is generally viewed as neutral to slightly negative by the market as it reduces insider ownership. However, the director retains substantial holdings and options, mitigating a strong negative signal.
Negatives
- An insider, specifically a Director and 10% Owner, sold a portion of their direct holdings in the company.
- While conducted under a Rule 10b5-1 plan, insider sales can sometimes be interpreted by the market as a lack of confidence, although this is less pronounced for pre-scheduled sales.
Risks
- Potential negative market perception due to an insider sale, even if pre-planned.
- The sale reduces the director's direct equity stake in the company, potentially reducing alignment with shareholder interests, though the remaining holdings and options are substantial.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- Director Gilbert Harrison, a 10% owner, sold 400 shares of Interparfums Inc. common stock for $133.96 per share on June 23, 2025. This transaction is considered a related party transaction as it involves a key insider.
Stakeholder Impact
- Shareholders: May interpret the insider sale as a signal, though its impact is mitigated by the Rule 10b5-1 plan and the director's remaining substantial holdings and options.
Key Dates
| Date | Description |
|---|---|
| 02/01/2022 | Earliest exercisable date for a tranche of stock options with an exercise price of $62.18 and expiration on 01/31/2026. |
| 02/01/2023 | Earliest exercisable date for a tranche of stock options with an exercise price of $62.18 and expiration on 01/31/2026. |
| 12/31/2023 | Earliest exercisable date for a tranche of stock options with an exercise price of $97.84 and expiration on 12/30/2028. |
| 02/01/2024 | Earliest exercisable date for a tranche of stock options with an exercise price of $62.18 and expiration on 01/31/2026. |
| 12/29/2024 | Earliest exercisable date for a tranche of stock options with an exercise price of $147.71 and expiration on 12/28/2029. |
| 12/31/2024 | Earliest exercisable date for a tranche of stock options with an exercise price of $97.84 and expiration on 12/30/2028. |
| 02/01/2025 | Earliest exercisable date for a tranche of stock options with an exercise price of $62.18 and expiration on 01/31/2026. |
| 06/23/2025 | Date of common stock sale transaction by Director Gilbert Harrison. |
| 06/25/2025 | Date the Form 4 was signed and filed. |
| 12/29/2025 | Earliest exercisable date for a tranche of stock options with an exercise price of $147.71 and expiration on 12/28/2029. |
| 12/31/2025 | Earliest exercisable date for a tranche of stock options with an exercise price of $97.84 and expiration on 12/30/2028, and for a tranche of stock options with an exercise price of $130.6 and expiration on 12/30/2030. |
| 01/31/2026 | Expiration date for multiple tranches of stock options with an exercise price of $62.18. |
| 12/29/2026 | Earliest exercisable date for a tranche of stock options with an exercise price of $147.71 and expiration on 12/28/2029. |
| 12/31/2026 | Earliest exercisable date for a tranche of stock options with an exercise price of $97.84 and expiration on 12/30/2028, and for a tranche of stock options with an exercise price of $130.6 and expiration on 12/30/2030. |
| 12/29/2027 | Earliest exercisable date for a tranche of stock options with an exercise price of $147.71 and expiration on 12/28/2029. |
| 12/31/2027 | Earliest exercisable date for a tranche of stock options with an exercise price of $97.84 and expiration on 12/30/2028, and for a tranche of stock options with an exercise price of $130.6 and expiration on 12/30/2030. |
| 12/28/2028 | Expiration date for multiple tranches of stock options with an exercise price of $147.71. |
| 12/30/2028 | Expiration date for multiple tranches of stock options with an exercise price of $97.84. |
| 12/29/2028 | Earliest exercisable date for a tranche of stock options with an exercise price of $147.71 and expiration on 12/28/2029. |
| 12/31/2028 | Earliest exercisable date for a tranche of stock options with an exercise price of $130.6 and expiration on 12/30/2030. |
| 12/28/2029 | Expiration date for multiple tranches of stock options with an exercise price of $147.71. |
| 12/31/2029 | Earliest exercisable date for a tranche of stock options with an exercise price of $130.6 and expiration on 12/30/2030. |
| 12/30/2030 | Expiration date for multiple tranches of stock options with an exercise price of $130.6. |
Keywords
Interparfums Inc., IPAR, SEC Form 4, Insider Sale, Beneficial Ownership, Director, Stock Options, Rule 10b5-1, Equity Transaction, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.